epigallocatechin gallate has been researched along with Corneal Neovascularization in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Wu, L; Ye, B; Zhu, L | 1 |
| Castro-Muñozledo, F; González-Robles, A; Gulias-Cañizo, R; Lagunes-Guillén, A; Sánchez-Guzmán, E | 1 |
| Chung, SK; Koh, CH; Lee, HS | 1 |
| Lu, M; Wu, LQ | 1 |
| Chang, CY; Chen, KH; Chen, ZY; Lin, FH; Liu, GS; Miyagawa, T; Tseng, CL; Wang, MC | 1 |
| Flores-Estrada, J; Gutiérrez-Sánchez, L; Sánchez-Huerta, V | 1 |
| Cao, R; Cao, Y | 1 |
7 other study(ies) available for epigallocatechin gallate and Corneal Neovascularization
| Article | Year |
|---|---|
Epigallocatechin gallate inhibits corneal neovascularization in ratalkaline burn model.
Topics: Animals; Burns, Chemical; Catechin; Corneal Neovascularization; Eye Proteins; Inflammation; Male; Neoplasm Proteins; Nerve Growth Factors; Nucleocytoplasmic Transport Proteins; Rats; Serpins; Sodium Hydroxide; Time Factors; Vascular Endothelial Growth Factor A | 2018 |
(-)-Epigallocatechin-3-gallate, reduces corneal damage secondary from experimental grade II alkali burns in mice.
Topics: Alkalies; Animals; Antioxidants; Burns, Chemical; Catechin; Caustics; Cell Cycle; Cell Differentiation; Cell Line; Cell Proliferation; Cornea; Corneal Neovascularization; Corneal Opacity; Epithelium, Corneal; Eye Burns; Mice; Rabbits; Sodium Hydroxide; Wound Healing | 2019 |
Effect of topical epigallocatechin gallate on corneal neovascularization in rabbits.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antioxidants; Blotting, Western; Catechin; Cornea; Corneal Neovascularization; Cyclooxygenase 2; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Ophthalmic Solutions; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2014 |
[Efficacy of epigallocatechin gallate in treatment of alkali burn injury of murine cornea].
Topics: Alkalies; Animals; Burns, Chemical; Catechin; Cornea; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Inflammation; Mice; Mice, Inbred C57BL; Neutrophils; RNA, Messenger; Vascular Endothelial Growth Factor A | 2015 |
Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Burns, Chemical; Catechin; Cell Survival; Corneal Neovascularization; Disease Models, Animal; Eye Burns; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Integrin alphaVbeta3; Mice, Inbred C57BL; Molecular Targeted Therapy; Nanoparticles; Oligopeptides; Ophthalmic Solutions | 2017 |
(-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization.
Topics: Animals; Catechin; Corneal Neovascularization; Eye; Humans; Interleukin-1beta; NF-kappa B; Transcription Factor RelA; Vision, Ocular | 2011 |
Angiogenesis inhibited by drinking tea.
Topics: Animals; Catechin; Cattle; Corneal Neovascularization; Drinking; Endothelium, Vascular; Mice; Neovascularization, Pathologic; Rats; Tea; Tumor Cells, Cultured | 1999 |